A rare cause of cholangitis: Fasciola hepatica

Turkish Journal of Gastroenterology

Volumn 21, Issue 3, 2010, Pages 329-330

  Aslan, Fatih ^a   Alper, Emrah ^a   Akpinar, Zehra ^a   Baydar, Behlül ^a   Aksöz, Mehmet Kadir ^a   Buyraç, Zafer ^a   Çekiç, Cem ^a   Ünsal, Belkis ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTHELMINTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CEFOPERAZONE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANAMNESIS; ANTIBIOTIC THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLANGITIS; CLINICAL FEATURE; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; JAUNDICE; LETTER; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; TURKEY (REPUBLIC);

CHOLANGITIS; FASCIOLIASIS; FEMALE; HUMANS; MIDDLE AGED;

EID: 77957654660     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0115     Document Type: Letter

References (11)

1. Adachi S, Kotani K, Shimizu T, et al. Asymptomatic fascioliasis. Intern Med 2005; 44: 1013-5.
2. Mas-Coma MS, Esteban JG, Bargues MD. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 1999; 77: 340-6.
3. Turhan O, Korkmaz M, Saba R, et al. Seroepidemiology of fascioliasis in the Antalya region and uselessness of eosinophil count as a surrogate marker and portable ultrasonography for epidemiological surveillance. Infez Med 2006; 14: 208-12.
4. Sezgin O, Altintas E, Disibeyaz S, et al. Hepatobiliary fascioliasis: clinical and radiologic features and endoscopic management. J Clin Gastroenterol 2004; 38: 285-91.
5. Arjona, R, Riancho, JA, Aguado, JM, et al. Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine (Baltimore) 1995; 74: 13-23.
6. Saba R, Korkmaz M, Inan D, et al. Human fascioliasis. Clin Microbiol Infect 2004; 10: 385-7.
7. Hillyer, GV, Soler de, Galanes M, et al. Use of the Falcon assay screening test - enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 1992; 46: 603.
8. Kabaalioglu A, Çubuk M, Senol U, et al. Fascioliasis: US, CT, and MRI findings with new observations. Abdom Imaging 2000; 25: 400-4.
9. Lim JH, Mairiang E, Ahn GH. Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom Imaging 2008; 33: 157-65.
10. Cevikol C, Karaali K, Senol U, et al. Human fascioliasis: MR imaging findings of hepatic lesions. Eur Radiol 2003; 13: 141-8.
11. Aksoy DY, Kerimoǧlu U, Oto A, et al. Fasciola hepatica infection: clinical and computerized tomographic findings of ten patients. Turk J Gastroenterol 2006; 17: 40-5.